Hypertrophic cardiomyopathy (HCM) is a common genetic heart condition that can lead to sudden cardiac-related death in young people. Scientists at the Allen Institute for Cells Science have developed a collection of human induced pluripotent stem cell lines to empower the global scientific community to better study and understand this disease under controlled conditions – developing a “disease in a dish” to help treat disease in the body. These cell lines are openly available in the Allen Cell Collection to accelerate research towards more effective treatments and therapies. Learn how these new tools will advance study—and hopefully treatment—of common genetic heart conditions.